Spots Global Cancer Trial Database for pet scan
Every month we try and update this database with for pet scan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study | NCT01266096 | Newly Diagnosed... Malignant Brain... | PET scan with 1... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Role of Axumin PET Scan in Germ Cell Tumor | NCT03426865 | Testis Cancer Germ Cell Tumor Testicular Canc... Germ Cell Tumor... Germ Cell Tumor... Testicular Neop... Testicular Germ... Testicular Yolk... Testicular Chor... Testicular Dise... Germ Cell Cance... Germ Cell Neopl... Germ Cell Cance... | Axumin PET scan | 18 Years - | University of Texas Southwestern Medical Center | |
| Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) | NCT01204203 | Mesothelioma | Zometa | 19 Years - | University of Alabama at Birmingham | |
| PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers | NCT00136890 | Non-small-cell ... | PET Imaging | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors | NCT02038738 | Neuroendocrine Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Carcinoid Tumor Islet Cell Tumo... Apudoma | 68Ga-DOTATATE w... | 18 Years - | Ochsner Health System | |
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | NCT00038038 | Squamous Cell C... Head and Neck N... Metastases, Neo... | 18F-fluoromison... PET scan | 18 Years - | M.D. Anderson Cancer Center | |
| PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | NCT01205646 | Prostate Cancer | zoledronate the... PET Scan | - | Barbara Ann Karmanos Cancer Institute | |
| PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers | NCT05581979 | Salivary Gland ... Rare Malignant ... | 68-Ga PSMA PET ... | 21 Years - 99 Years | National Cancer Centre, Singapore | |
| PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer | NCT02088775 | Adult Primary H... Advanced Adult ... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage D Adult P... Unspecified Adu... | PET scan CT Scan hepatic artery ... | 18 Years - | Fox Chase Cancer Center | |
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors | NCT02038738 | Neuroendocrine Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Carcinoid Tumor Islet Cell Tumo... Apudoma | 68Ga-DOTATATE w... | 18 Years - | Ochsner Health System | |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
| Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide | NCT01458366 | Non-Hodgkin's L... | Bendamustine Ofatumumab Carboplatin Etoposide CT Scan PET Scan Stem Cell Trans... | 18 Years - | Thomas Jefferson University | |
| De-escalation Study for Stage IIa/IIb < 3 cm Seminoma | NCT05529251 | Seminoma Stage II | Radiotherapy bo... Carboplatin AUC... 3 cycles of EP | 18 Years - | Centre Leon Berard | |
| Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | NCT01543659 | Prostate Cancer | 89Zr-DFO-huJ591 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer | NCT00588185 | Prostate Cancer | [18F]-Fluoro-2-... | - | Memorial Sloan Kettering Cancer Center | |
| 68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer | NCT05160051 | Tumor, Solid | 68Ga-FAPI-46 PE... | 18 Years - | University Hospital, Essen | |
| Effect of Metformin on Breast Cancer Metabolism | NCT01266486 | Breast Cancer | Metformin | 18 Years - | Oxford University Hospitals NHS Trust | |
| Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer | NCT01621529 | Infiltrating Du... | 18 Years - | Centre Henri Becquerel | ||
| Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. | NCT00188253 | Nasopharyngeal ... | - | University Health Network, Toronto | ||
| CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma | NCT05289193 | Melanoma Melanoma Stage ... | PET Scan Nivolumab Ipilimumab Surgical Resect... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II) | NCT03853915 | Cervical Cancer | [18-F]- FDG - P... | 18 Years - | University Health Network, Toronto | |
| PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | NCT00201942 | Breast Cancer | PET scan | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | NCT00379197 | Breast Cancer | naltrexone PET scan | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer | NCT01774071 | Prostate Cancer | 89Zr- DFO-MSTP2... 89Zr DFO-MSTP21... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC) | NCT00832715 | Lung Cancer | EBUS-TBNA | 18 Years - | M.D. Anderson Cancer Center | |
| F-18 Sodium Fluoride in Prostate Cancer | NCT01240551 | Prostate Neopla... | F-18 NaF | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging | NCT04721756 | Neoplasms Neoplasms Malig... | 18F-LY3546117 I... PET Scan | 18 Years - | Avid Radiopharmaceuticals | |
| PET/CT-Assessment of Liver Tumor Ablation | NCT02018107 | Liver Tumor Liver Neoplasms | N-13 ammonia or... PET scan | 18 Years - | Dana-Farber Cancer Institute | |
| Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy | NCT02349022 | Prostate Cancer | [89Zr]Df-IAB2M | 18 Years - | ImaginAb, Inc. | |
| 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer | NCT01993160 | Prostate Cancer | Fluorocholine (... PET scan Whole body MRI | 18 Years - 99 Years | University Health Network, Toronto | |
| 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases | NCT02037945 | Brain Metastase... | 18F-FCH PET Sca... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer | NCT01923727 | Metastatic Pros... | [89Zr]Df-IAB2M | 18 Years - | ImaginAb, Inc. | |
| (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas | NCT01281982 | Low Grade Gliom... Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Oligoastrocytom... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study. | NCT00759382 | Non Small Cell ... | 18 Years - | European Lung Cancer Working Party | ||
| Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma | NCT00934505 | Oesophageal Can... | 18 Years - | Centre Henri Becquerel | ||
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | NCT00038038 | Squamous Cell C... Head and Neck N... Metastases, Neo... | 18F-fluoromison... PET scan | 18 Years - | M.D. Anderson Cancer Center | |
| Imaging and Biomarkers of Hypoxia in Solid Tumors | NCT01123005 | Neoplasms | PET Scan EF5 Carbogen Dichloroacetate | 18 Years - | Stanford University | |
| Imaging and Biomarkers of Hypoxia in Solid Tumors | NCT01123005 | Neoplasms | PET Scan EF5 Carbogen Dichloroacetate | 18 Years - | Stanford University | |
| IL2 Imaging in Metastatic Melanoma | NCT02922283 | Melanoma | IL2-PET scan Tumor biopsy CT scan Biopsy of non-t... | 18 Years - | University Medical Center Groningen | |
| PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers | NCT00136890 | Non-small-cell ... | PET Imaging | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma | NCT01582204 | Renal Cancer | 124IcG250 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer | NCT02088775 | Adult Primary H... Advanced Adult ... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage D Adult P... Unspecified Adu... | PET scan CT Scan hepatic artery ... | 18 Years - | Fox Chase Cancer Center | |
| Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients | NCT00139204 | Prostate Cancer | C11 Methionine ... | 18 Years - | Dana-Farber Cancer Institute | |
| 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer | NCT02121600 | Prostate Cancer | [F-18]-FCH PET scan MRI scan | 18 Years - | Lawson Health Research Institute | |
| Study of 18F-Fluoro-PEG6-IPQA | NCT01320059 | Lung Cancer | 18F-PEG6-IPQA Positron emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans | NCT02165683 | Pediatric Cance... | 12 Years - 29 Years | University of Kentucky | ||
| A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | NCT05133440 | Prostate Cancer | Radium dichlori... PET Scan | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of 18F-Fluoro-PEG6-IPQA | NCT01320059 | Lung Cancer | 18F-PEG6-IPQA Positron emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | NCT05133440 | Prostate Cancer | Radium dichlori... PET Scan | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study | NCT01269593 | Non-Hodgkin's L... Myeloma Active Solid Ma... | PET Imaging usi... | 18 Years - 90 Years | Memorial Sloan Kettering Cancer Center | |
| Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study | NCT05632601 | Cardiovascular ... | PET scan | 25 Years - 55 Years | Ottawa Heart Institute Research Corporation | |
| Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy | NCT02349022 | Prostate Cancer | [89Zr]Df-IAB2M | 18 Years - | ImaginAb, Inc. | |
| R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | NCT00809341 | Non-Hodgkin's L... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone Ifosfamide Carboplatin Etoposide High-dose cyclo... PET scan | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors | NCT03465618 | Brain Cancer Pituitary Adeno... | 89Zr-DFO-cRGDY-... Blood and Urine... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 | NCT05737615 | Pancreatic Canc... Pancreatic Duct... Metastatic Panc... Primary Pancrea... Metastatic Panc... | PET Scan hu5B1-TCO 64Cu-Tz-SarAr Pharmacokinetic... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer | NCT05141643 | Pancreatic Canc... Pancreatic Duct... | PET Scan | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Imaging Brain Tumors With FACBC and Methionine | NCT00597246 | Brain Cancer CNS Cancer | FACBC, Methioni... PET Scan | - | Memorial Sloan Kettering Cancer Center | |
| Imaging Brain Tumors With FACBC and Methionine | NCT00597246 | Brain Cancer CNS Cancer | FACBC, Methioni... PET Scan | - | Memorial Sloan Kettering Cancer Center | |
| 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer | NCT01396382 | Neuroendocrine ... | 68Ga-DOTATATE P... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma | NCT01582204 | Renal Cancer | 124IcG250 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans | NCT02165683 | Pediatric Cance... | 12 Years - 29 Years | University of Kentucky | ||
| Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | NCT01543659 | Prostate Cancer | 89Zr-DFO-huJ591 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| F-18 Sodium Fluoride in Prostate Cancer | NCT01240551 | Prostate Neopla... | F-18 NaF | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025 | NCT02095210 | HER2-positive B... | Radiolabeled [6... | 18 Years - | Herlev Hospital | |
| Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study | NCT05632601 | Cardiovascular ... | PET scan | 25 Years - 55 Years | Ottawa Heart Institute Research Corporation | |
| IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types | NCT04285996 | Cancer | PET Scan | 18 Years - | Queen Mary University of London | |
| Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer | NCT01206881 | Breast Cancer | pegylated lipos... | 18 Years - 75 Years | Herlev Hospital | |
| Imaging Young Myeloma (IMAgerie JEune Myélome) | NCT01309334 | Multiple Myelom... | PET scan MRI | 18 Years - 65 Years | Nantes University Hospital | |
| A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | NCT05133440 | Prostate Cancer | Radium dichlori... PET Scan | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | NCT00201942 | Breast Cancer | PET scan | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers | NCT05581979 | Salivary Gland ... Rare Malignant ... | 68-Ga PSMA PET ... | 21 Years - 99 Years | National Cancer Centre, Singapore | |
| Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab | NCT00613847 | Solid Tumors | PET Imaging wit... PET Imaging wit... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) | NCT05681260 | T-cell Lymphobl... | Prednisone,Vinc... Prednisone,Vinc... Prednisone,Vinc... | 12 Months - 18 Years | Children's Cancer Group, China | |
| Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients | NCT00139204 | Prostate Cancer | C11 Methionine ... | 18 Years - | Dana-Farber Cancer Institute | |
| Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT | NCT01261585 | Bronchial Neopl... Carcinoma, Non-... | 18 Years - 75 Years | Centre Henri Becquerel | ||
| Imaging Brain Tumors With FACBC and Methionine | NCT00597246 | Brain Cancer CNS Cancer | FACBC, Methioni... PET Scan | - | Memorial Sloan Kettering Cancer Center | |
| Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation | NCT00313027 | Head and Neck C... Carcinoma, Squa... Head and Neck C... | PET scan | 18 Years - | Stanford University | |
| Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer | NCT05141643 | Pancreatic Canc... Pancreatic Duct... | PET Scan | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer | NCT00605488 | Breast Cancer Head and Neck C... Prostate Cancer | novel PET trace... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | NCT01205646 | Prostate Cancer | zoledronate the... PET Scan | - | Barbara Ann Karmanos Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
